36284120|t|Ameliorative effect of oregano (Origanum vulgare) versus silymarin in experimentally induced hepatic encephalopathy.
36284120|a|Hepatic encephalopathy (HE) is a deterioration of brain function in patients suffering from chronic liver disease, cirrhosis as a result of elevated blood ammonia and the production of pseudo-neurotransmitters. Herein, we investigated the chemical composition of hexane extract from Origanum vulgare (O. vulgare) leaves as well as its possible protective effects against thioacetamide (TAA)-induced HE in rats. GC-MS analysis of the extract revealed tentative identification of twenty-five compounds (82.93%), predominated by cholesten-3-one (27.30%), followed by gamma-tocopherol (13.52%), alpha-tocopherol (5.01%), beta-amyrin (5.24%) and alpha-amyrin (4.89%). Albino rats were distributed into seven groups (n = 7). G1 served as negative control; G2 and G3 served as controls treated with O. vulgare (100 and 200 mg/kg/p.o b.w, respectively); G4 served as TAA-positive control group (100 mg/kg/day/i.p., three alternative days per week for six weeks); G5, G6, and G7 served as TAA -induced HE rat model that received O. vulgare 100, O. vulgare 200, and silymarin (100 mg/kg of SILY, as standard drug), respectively. TAA showed depressive and anxiety-like behaviors in forced swimming test (FST) and reduction of cognitive score in elevated plus-maze test (EPMT) as well as impairment of locomotor and exploratory activities in open-field test (OFT). TAA caused a significant decline in body weight gain; however, the relative liver weight and brain water content were statistically increased. TAA-intoxicated rats showed significant increase of serum biomarker enzymes, proinflammatory cytokines, blood ammonia levels, brain serotonin, acetyl cholinesterase and cellular lipid peroxidation with significant decrease of brain dopamine, norepinephrine, antioxidant status. The hepatoprotective/neuro-protective activities of O. vulgare was found to be comparable with that of SILY in HE rats model. Where, treatment of TAA-intoxicated rats with O. vulgare attenuated anxiety, depressive-related behaviors, and reduced the biochemical changes in HE-induced by TAA. Therefore, O. vulgare could be an excellent hepato-/neuroprotective against hepatic injury and HE via improving the oxidative/inflammatory status through its antioxidant and neuro-modulatory properties and its effect is equal to that of SILY.
36284120	32	48	Origanum vulgare	Species	39352
36284120	57	66	silymarin	Chemical	MESH:D012838
36284120	93	115	hepatic encephalopathy	Disease	MESH:D006501
36284120	117	139	Hepatic encephalopathy	Disease	MESH:D006501
36284120	141	143	HE	Disease	MESH:D006501
36284120	164	181	of brain function	Disease	MESH:D001927
36284120	185	193	patients	Species	9606
36284120	209	230	chronic liver disease	Disease	MESH:D008107
36284120	232	241	cirrhosis	Disease	MESH:D005355
36284120	272	279	ammonia	Chemical	MESH:D000641
36284120	380	386	hexane	Chemical	MESH:D006586
36284120	400	416	Origanum vulgare	Species	39352
36284120	418	428	O. vulgare	Species	39352
36284120	488	501	thioacetamide	Chemical	MESH:D013853
36284120	503	506	TAA	Chemical	MESH:D013853
36284120	516	518	HE	Disease	MESH:D006501
36284120	522	526	rats	Species	10116
36284120	643	658	cholesten-3-one	Chemical	-
36284120	681	697	gamma-tocopherol	Chemical	MESH:D024504
36284120	708	724	alpha-tocopherol	Chemical	MESH:D024502
36284120	734	745	beta-amyrin	Chemical	MESH:C036380
36284120	758	770	alpha-amyrin	Chemical	MESH:C000654244
36284120	787	791	rats	Species	10116
36284120	909	919	O. vulgare	Species	39352
36284120	976	979	TAA	Chemical	MESH:D013853
36284120	1097	1100	TAA	Chemical	MESH:D013853
36284120	1110	1112	HE	Disease	MESH:D006501
36284120	1113	1116	rat	Species	10116
36284120	1137	1147	O. vulgare	Species	39352
36284120	1153	1163	O. vulgare	Species	39352
36284120	1173	1182	silymarin	Chemical	MESH:D012838
36284120	1197	1201	SILY	Chemical	-
36284120	1236	1239	TAA	Chemical	MESH:D013853
36284120	1247	1269	depressive and anxiety	Disease	MESH:D001007
36284120	1470	1473	TAA	Chemical	MESH:D013853
36284120	1613	1616	TAA	Chemical	MESH:D013853
36284120	1629	1633	rats	Species	10116
36284120	1723	1730	ammonia	Chemical	MESH:D000641
36284120	1745	1754	serotonin	Chemical	MESH:D012701
36284120	1756	1777	acetyl cholinesterase	Gene	83817
36284120	1791	1796	lipid	Chemical	MESH:D008055
36284120	1845	1853	dopamine	Chemical	MESH:D004298
36284120	1855	1869	norepinephrine	Chemical	MESH:D009638
36284120	1943	1953	O. vulgare	Species	39352
36284120	1994	1998	SILY	Chemical	-
36284120	2002	2004	HE	Disease	MESH:D006501
36284120	2005	2009	rats	Species	10116
36284120	2037	2040	TAA	Chemical	MESH:D013853
36284120	2053	2057	rats	Species	10116
36284120	2063	2073	O. vulgare	Species	39352
36284120	2085	2092	anxiety	Disease	MESH:D001007
36284120	2094	2104	depressive	Disease	MESH:D003866
36284120	2163	2165	HE	Disease	MESH:D006501
36284120	2177	2180	TAA	Chemical	MESH:D013853
36284120	2193	2203	O. vulgare	Species	39352
36284120	2258	2272	hepatic injury	Disease	MESH:D056486
36284120	2277	2279	HE	Disease	MESH:D006501
36284120	2308	2320	inflammatory	Disease	MESH:D007249
36284120	2419	2423	SILY	Chemical	-
36284120	Negative_Correlation	MESH:D004298	MESH:D013853
36284120	Negative_Correlation	MESH:D009638	MESH:D013853
36284120	Negative_Correlation	MESH:D012838	MESH:D006501
36284120	Positive_Correlation	MESH:D000641	MESH:D001927
36284120	Positive_Correlation	MESH:D013853	MESH:D006501
36284120	Positive_Correlation	MESH:D012701	MESH:D013853
36284120	Positive_Correlation	MESH:D000641	MESH:D013853
36284120	Positive_Correlation	MESH:D013853	MESH:D001007
36284120	Positive_Correlation	MESH:D013853	83817
36284120	Negative_Correlation	MESH:D012838	MESH:D013853
36284120	Association	MESH:D008055	MESH:D013853

